Study at a glance
Can active vitamin D change how immune cells attach to blood-vessel linings?
Two studies used human blood-vessel lining cells grown in the laboratory to examine responses to an inflammatory signal. They tested active vitamin D, not ordinary vitamin D3 supplements taken by people. One study measured molecules that help immune cells interact with the lining. The other measured immune-cell attachment itself.
Did active vitamin D change molecules involved in immune-cell attachment?
Active vitamin D given before the inflammatory signal reduced two attachment-related molecules. Reducing the vitamin D receptor, the protein that receives vitamin D signals, weakened some responses. However, one result did not fit the simple explanation proposed for how the receptor worked. The study therefore suggests a possible mechanism with an unresolved inconsistency. It did not directly demonstrate less immune-cell attachment.
Did active vitamin D reduce actual immune-cell attachment?
Researchers combined vessel-lining cells with a laboratory line of immune cells and counted attachment using fluorescent labels. Active vitamin D did not significantly reduce attachment when given with the inflammatory signal or after it had begun. There were three independent experiments with repeated measurements. Measurements of molecules in the surrounding liquid did not directly show how much was present on the cell surface.
Do these cell studies show better blood flow or fewer heart attacks?
The experiments differed in timing, strength of the inflammatory challenge and what they measured. They did not establish which difference explained the contrasting results. No significant attachment reduction does not prove that every small effect is absent, but it also does not demonstrate benefit. Neither study measured better blood flow, fewer heart attacks or fewer strokes. They do not establish a supplement dose, blood target or protection for the heart and blood vessels.
Read the full article below ↓Two 2025 cell studies examined whether the active vitamin D hormone changes inflammatory interactions at the blood-vessel lining. One reported lower expression of selected adhesion molecules, with an important inconsistency in its proposed receptor mechanism. The other measured immune-cell attachment directly and found no significant reduction. For the detailed methods and appraisal, read Vitamin D, Endothelial Inflammation and Immune-Cell Adhesion: Full Study.
What the positive experiment measured
Xia and colleagues studied human umbilical vein endothelial cells in culture. They used calcitriol, the active vitamin D hormone, rather than ordinary oral vitamin D3. After stimulation with tumour necrosis factor alpha, an inflammatory messenger, calcitriol pretreatment reduced expression of vascular cell adhesion molecule 1 and E-selectin. These are molecules involved in interactions between immune cells and the vessel lining.
This addressed one part of endothelial function. It did not directly show fewer immune cells attaching, a stronger vessel barrier or fewer cardiovascular events. Reducing vitamin D receptor expression weakened some reported responses. However, Figure 3’s result for nuclear p65, a component of an inflammatory gene-regulation system, does not follow the simple receptor-dependent account. The mechanism therefore needs qualification and clarification.
What the functional adhesion experiment found
Marino and colleagues combined endothelial cells with a laboratory monocyte cell line. Monocytes are immune cells that circulate in blood. The researchers measured attachment using labelled cells and fluorescence after washing away cells that had not adhered. Calcitriol did not significantly reduce attachment when given with the inflammatory stimulus or after stimulation had begun.
The adhesion analyses involved three independent experiments, with repeated technical measurements. This was not a clinical trial. The researchers also measured soluble adhesion-related markers in culture liquid; these do not directly establish the amount of protein displayed on the cell surface. A dose-unit discrepancy in the viability methods is a further reporting limitation.
Why the findings differ without proving a single explanation
The experiments used different inflammatory stimulus strengths, treatment schedules, culture histories and endpoints. The inflammatory signalling overview explains why those conditions matter. A molecular response in one protocol does not guarantee a functional adhesion response in another. The studies did not test which difference explained the contrasting findings.
A null result means no statistically established reduction under the tested conditions. It does not exclude every smaller effect or every other biological setting. Equally, possible explanations for a null finding are not evidence that a benefit actually occurred. Both the positive observations and their limitations belong in the interpretation.
What this means for cardiovascular claims
Neither paper measured blood flow or vascular tone, the contraction and relaxation of vessel walls. Neither tested heart attacks, strokes or atherosclerotic plaque progression in people. Adhesion-related signalling is a candidate risk pathway, not a validated substitute for those outcomes.
The evidence supports further investigation of specific endothelial mechanisms. It does not establish that taking vitamin D prevents cardiovascular disease, define a supplement dose or identify an optimal blood concentration. The active hormone used in a culture dish must not be treated as interchangeable with nutritional supplementation.
Scientific sources
Xia Y, Liu S, Shao Q, Feng Y, Jin B, Zhang Q. 1α, 25-dihydroxyvitamin D3 attenuates tumor necrosis factor-α-induced endothelial cell injury by modulating the tumor necrosis factor-α/nuclear factor kappa-B pathway. CytoJournal. 2025;22:70. DOI: 10.25259/Cytojournal_220_2024. PMID: 41216236. Endothelial signalling experiment; interpret the receptor mechanism with the reporting qualifications discussed above.
Marino M, Venturi S, Møller P, Rendine M, Martini D, Riso P, Del Bo’ C. Vitamin D does not mitigate monocyte adhesion to vascular endothelial cells in an in vitro pro-inflammatory model. PharmaNutrition. 2025;34:100454. DOI: 10.1016/j.phanu.2025.100454. The university record identifies the publication and links its published version; the complete author-uploaded article was also examined.
Related reading
In Vivo Regulation of Signal Transduction Pathways by Vitamin D Stabilizes Homeostasis of Human Immune Cells and Counteracts Molecular Stress
Eight of the pathways show an approximately even contribution of up: and downregulated genes, suggesting that the actions of vitamin D stabilize homeostasis of the physiological processes driven by the respective signaling cascades.
Original paper ↗Read more →Sporadic PCDH18 somatic mutations in EpCAM-positive hepatocellular carcinoma
In this study, we evaluated the relationship between somatic mutations and epithelial cell adhesion molecule positive (EpCAM+) CSCs.
Original paper ↗Read more →The Impact of the Metabolic Syndrome and Its Components on Resting Energy Expenditure
Ninety-five (53%) participants had MetS (MetS+), while 85 (47%) were without MetS (MetS−).
Original paper ↗Read more →Vitamin D, Endothelial Inflammation and Immune-Cell Adhesion: Full Study
Examine vitamin D research on endothelial inflammatory signalling and immune-cell adhesion, with clear limits on what it establishes about cardiovascular risk.
Read more →Germanane Quantum Dots Promote Metabolic Reprogramming of Immune Cells Toward Regulatory T Cells and Suppress Inflammation In Vitro and In Vivo
Recently, nanomaterials have emerged as a tool in developing novel therapies against inflammatory diseases.
Original paper ↗Read more →Impaired Vitamin D Signaling in Endothelial Cell Leads to an Enhanced Leukocyte-Endothelium Interplay: Implications for Atherosclerosis Development
Our aim was to assess the role of basal levels of vitamin D receptor (VDR) on the early leukocyte recruitment and related endothelial cell-adhesion-molecule expression, as essential prerequisites for the onset of atherosclerosis.
Original paper ↗Read more →Calcitriol Reduces the Inflammation, Endothelial Damage and Oxidative Stress in AKI Caused by Cisplatin
Cisplatin treatment is one of the most commonly used treatments for patients with cancer.
Original paper ↗Read more →Combined exposure to fine particulate matter and high glucose aggravates endothelial damage by increasing inflammation and mitophagy: the involvement of vitamin D
Thus, this study aimed to investigate the combined effects of PM2.5 and high glucose on endothelial damage.
Original paper ↗Read more →Epidemiology of 40 blood biomarkers of one-carbon metabolism, vitamin status, inflammation, and renal and endothelial function among cancer-free older adults
Imbalances of blood biomarkers are associated with disease, and biomarkers may also vary non-pathologically across population groups.
Original paper ↗Read more →Adipose tissue inflammation and VDR expression and methylation in colorectal cancer
Lack of vitamin D (VD) has been associated with colorectal cancer (CRC).
Original paper ↗Read more →Differences in Chronic Low-Grade Inflammation and Metabolic Disturbances between VDR Genotypes in an Ethnically Homogenous Postmenopausal Female Population from Poland
The aim of this study was to assess the differentiation by the VDR genotype of the risk factors for so-called chronic low-grade inflammation and metabolic disorders.
Original paper ↗Read more →Inflammation and Vitamin D Receptor Polymorphism: Impact on All-Cause and Cardiovascular Mortality in Mexican Women on Dialysis
This study aimed to determine how these factors affect mortality.
Original paper ↗Read more →Vitamin D Genetics Beyond Serum 25(OH)D: VDR rs2228570 (FokI) Polymorphism, Inflammation, and Quality of Life in Orthopedic Patients
This study investigated the rs2228570 (FokI) variant in relation to inflammatory, hematologic, and patient-reported outcomes in orthopedic patients.
Original paper ↗Read more →Vitamin D receptor expression controls proliferation of naïve CD8+ T cells and development of CD8 mediated gastrointestinal inflammation
Vitamin D receptor (VDR) deficiency contributes to the development of experimental inflammatory bowel disease (IBD) in several different models.
Original paper ↗Read more →Vitamin D Receptor Polymorphisms Are Associated with 25(OH)D3 Concentrations and Systemic Inflammation in Decompensated Cirrhosis
In this study, we aimed to investigate the impact of Vitamin D receptor (VDR) polymorphisms (SNPs), as surrogates for functional relationships, on 25(OH)D3 status and systemic inflammation in decompensated liver cirrhosis.
Original paper ↗Read more →Vitamin D’s Effect on the Proliferation and Inflammation of Human Intervertebral Disc Cells in Relation to the Functional Vitamin D Receptor Gene FokI Polymorphism
The aim of this study was to investigate the response of disc cells to vitamin D in terms of the regulation of proliferation, metabolism, and inflammatory processes, with a particular focus on the FokI VDR genotype.
Original paper ↗Read more →Vitamin D3 inhibits lipopolysaccharide-induced placental inflammation through reinforcing interaction between vitamin D receptor and nuclear factor kappa B p65 subunit
The present study investigated the effects of maternal VitD3 supplementation during pregnancy on LPS-induced placental inflammation and fetal intrauterine growth restriction (IUGR).
Original paper ↗Read more →High glucose-induced injury in human umbilical vein endothelial cells is alleviated by vitamin D supplementation through downregulation of TIPE1
Diabetes mellitus (DM) and its associated vascular complications have become a worldwide health concern.
Original paper ↗Read more →Macronutrient and micronutrient requirements in sickle cell disease across age groups: a narrative review
Large, high‑quality randomised controlled trials are urgently needed to establish evidence‑based nutritional guidelines for SCD.
Original paper ↗Read more →Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury
The active form of vitamin D (1,25(OH)2D3) has been shown to inhibit development of inflammatory bowel disease (IBD) in IL-10 KO mice.
Original paper ↗Read more →Vitamin D and Cytokine Balance
Explains how vitamin D relates to cytokine balance, including immune-cell communication, pro: and anti-inflammatory signalling, tissue-specific responses, and resolution biology, without making treatment claims.
Read more →Original sources
1α, 25-dihydroxyvitamin D3 attenuates tumor necrosis factor-α-induced endothelial cell injury by modulating the tumor necrosis factor-α/nuclear factor kappa-B pathway
Published in CytoJournal (2025).
Publication details
Xia Y, Liu S, Shao Q, Feng Y, Jin B, Zhang Q. 1α, 25-dihydroxyvitamin D3 attenuates tumor necrosis factor-α-induced endothelial cell injury by modulating the tumor necrosis factor-α/nuclear factor kappa-B pathway. CytoJournal. 2025;22:70. DOI: 10.25259/Cytojournal_220_2024. PMID: 41216236. Endothelial signalling experiment; interpret the receptor mechanism with the reporting qualifications discussed above.
Vitamin D does not mitigate monocyte adhesion to vascular endothelial cells in an in vitro pro-inflammatory model
Published in PharmaNutrition (2025).
Publication details
Marino M, Venturi S, Møller P, Rendine M, Martini D, Riso P, Del Bo’ C. Vitamin D does not mitigate monocyte adhesion to vascular endothelial cells in an in vitro pro-inflammatory model. PharmaNutrition. 2025;34:100454. DOI: 10.1016/j.phanu.2025.100454. The university record identifies the publication and links its published version; the complete author-uploaded article was also examined.